SKN | Nuvation Bio Inc. Advances Toward $140 Million IPO to Accelerate Pipeline of Targeted Oncology Therapies
Nuvation Bio Inc., a clinical-stage biotechnology company developing next-generation cancer therapies, is preparing a $140 million initial public offering (IPO) to advance its portfolio...
SKN | Terns Pharmaceuticals, Inc. Prepares $150 Million IPO to Advance Obesity and Oncology Drug Pipeline
Terns Pharmaceuticals, Inc., a rapidly emerging clinical-stage biotechnology company focused on developing small-molecule therapies for obesity and oncology, is preparing a $150 million initial...
SKN | Jazz Pharmaceuticals plc Targets $300 Million IPO Expansion to Strengthen Sleep, Oncology, and Rare Disease Portfolio
Jazz Pharmaceuticals plc, a global biopharmaceutical company specializing in sleep medicine, oncology, and rare neurological disorders, is preparing a $300 million initial public offering...
SKN | Satellite Manufacturer York Space Systems Files for an Estimated $400 Million IPO
York Space Systems, a U.S.-based small satellite manufacturer, has filed for an estimated $400 million initial public offering, aiming to capitalize on the growing...
SKN | Digital Asset-Focused SPAC Aperture AC Files for a $90 Million IPO
Aperture AC, a special purpose acquisition company (SPAC) with a focus on digital asset markets, has filed for a $90 million initial public offering,...
